Bidirectional Constitutive Promoter and Uses, and Transfection Methods for B. Microti
AssigneeMJKS Research LLC
InventorsKavitha Govindasamy, Agam P. Singh, Dabbu Kumar Jaijyan
Life of this patent
Estimating the term…
Loading patent…
AssigneeMJKS Research LLC
InventorsKavitha Govindasamy, Agam P. Singh, Dabbu Kumar Jaijyan
Estimating the term…
The present invention is directed to a novel B. microti-based promoter and expression system. The present invention is also directed to a novel method of transfecting B. microti by electroporation, the resulting transfected B. microti parasite cell lines, and optionally, B. microti transfected with a particular novel promoter. In some embodiments, transgenic B. microti parasites that express reporter genes and their uses are provided. In certain embodiments, a multi-functional promoter controls multiple genes, e.g. a bifunctional promoter may control a gene of interest and a reporter or selection gene. The promoter may be particularly useful to control expression of apicomplexan genes and form apicomplexan proteins, e.g., without limitation, those of Babesia parasites. In embodiments, expression systems comprising the promoter are provided. In certain embodiments, B. microti-based systems that express reporter genes are provided. Other expression platforms include surrogate and non-surrogate systems, transgenic parasites, bacterial, fungal, algae, and mammalian platforms, among others. These and other embodiments may be advantageously used for protein expression, diagnostic tools, disease diagnosis, identification of novel genes for drug discovery and vaccine development, recombinant antigens and other immunogens for vaccination, improved vaccine production, gene therapy, analysis of parasite proteins including structure-function analysis, candidate drug screening and profiling, and many related applications. Transfected B. microti parasites expressing reporter genes may advantageously be used e.g. in the study of the B. microti life cycle and host-parasite interaction analysis.
A heterologous expression system comprising a promoter sequence having 60% or more identity to SEQ ID NO:1 or a contiguous part thereof, wherein the contiguous part thereof has a length of 100 nucleotides or more.
A method of expressing a gene product or protein in an expression system, wherein the expression system comprises a promoter operably linked to control expression of an ORF, CDS or gene, wherein the sequence of the promoter has 60% or more identity to SEQ ID NO:1, or a contiguous part thereof, wherein the contiguous part thereof has a length of 100 nucleotides or more.
A method of stably transfecting B. microti, wherein the transfection is performed by electroporation.
A Babesia microti parasite cell line wherein the cell line comprises a heterologous expression system, and wherein the heterologous expression system comprises one or more reporter gene, and wherein the reporter gene, or a combination of two reporter genes, is selected from the group comprising:
A method of expressing a gene product or protein in an expression system, wherein the cell line is a Babesia microti parasite cell line stably transfected with a heterologous expression system by electroporation, and the stably transfected B. microti parasite cell line expresses one or more reporter gene.
Dependencies are inferred from the claim text.